Acute Myeloid Leukemia Treatment Market Outlook Size, Business Revenue Forecast, Leading Competitors
The acute myeloid leukemia (AML) treatment market is rising due to increasing stem cell transplant rates and a number of research pipeline drugs. Most patients are geriatrics aged 65 or over. Population with certain genetic disorders such as Shwachman syndrome, Diamond Blackfan Syndrome, Down syndrome, and certain blood disorder have greater chances of developing AML Acute Myeloid Leukemia...
0 Comments 0 Shares 3K Views 0 Reviews